January 16, 2014. Location: Georgetown University Hotel and Conference Center
Speaker: Steven Teitelbaum, MD Messing Professor of Pathology and Immunology, Professor of Medicine, Washington University School of Medicine
Title "The osteoclast; what does it do and how does it do it?"
Educational objectives:
Understand the pathogenesis of osteopetrosis
Understand how the osteoclast dictates bone mass
Appreciate the importance of novel approaches to osteoporosis treatment, based on new insights into the molecular and cellular mechanisms of osteoporosis
February 27, 2014 Location: Positano Restaurant Bethesda MD
Speaker: John P Bilezikian, MD
Dorothy L. and Daniel H. Silberberg Professor of Medicine; Professor of Pharmacology, Cief of Division of Endocrinology; Director of the Metabolic Bone Diseases Program;
Columbia University, New York
Title: "Sclerostin Antagonism: Clinical Applications and Therapeutic Potential"
Educational objectives:
Update understanding on the regulation of bone formation and resorption
Discuss the contribution of sclerostin overproduction in bone disease
Review available evidence for treatment benefits and limitations with sclerostin antagonists
May 15, 2014 Location: Wildfire Steakhouse Tyson's Galleria 3rd floor, McLean VA
Speaker: Robert A. Adler, MD
Professor and Chief, Endocrinology
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Title: “Osteoporosis in Men”
Educational Objectives:
Review practice guidelines for the management of osteoporosis in man
Discuss the role of sex steroids and other metabolic factors influencing fracture mortality and frequency in men
Recognize racial differences in skeletal structure and the implications for osteoporosis evaluation and treatment in men
July 10, 2014 Location: Georgetown University
Speaker: Dennis M. Black, PhD
Professor in Residence, Division of Clinical Trials & Multicenter Studies
Department of Epidemiology and Biostatistics
University of California, San Francisco, USA
Title: “How Long Should We Treat?"
Educational Objectives:
Understand the efficacy of bisphosphonates including in whom they are of greatest benefit
Understand recent news about the incidence, severity and clinical impact of atypical femur fractures and ONJ and their possible relationship to bisphosphonate
Be able to balance, for individual patients, the benefits versus risks for bisphosphonates treatment and alternate therapies over the short and long term
October 25, 2014 Location: Bistro Provence, Bethesda
Speaker: Clifford Rosen MD
Professor of Medicine
Maine Medical Center Research Institute
Director, Clinical and Translational Research
Title “Aging Effects on Bone, Fat, and Muscle"
Educational Objectives:
─ Understand energy metabolism in bone and muscle
─ Discuss the effects of aging on bone fat and remodeling
─ Review treatment options for the prevention of fractures in aging men and women